Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa®), in antiretroviral-naïve patients: A 48-week, multicentre, randomized study (Lake Study)
Titel:
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa®), in antiretroviral-naïve patients: A 48-week, multicentre, randomized study (Lake Study)
Auteur:
Echeverría, P. Negredo, E. Carosi, G. Gálvez, J. Gómez, J.L. Ocampo, A. Portilla, J. Prieto, A. López, J.C. Rubio, R. Mariño, A. Pedrol, E. Viladés, C. del Arco, A. Moreno, A. Bravo, I. López-Blazquez, R. Pérez-Alvarez, N. Clotet, B.